NLRX1/NOD5 deficiency does not affect MAVS signalling (original) (raw)
- Correspondence
- Published: 27 May 2011
Cell Death & Differentiation volume 18, page 1387 (2011)Cite this article
- 2056 Accesses
- 70 Citations
- 3 Altmetric
- Metrics details
Subjects
Dear Editor,
NLRX1/NOD5 belongs to the NOD clade of the NOD-like receptor (NLR) family. NLRs have emerged as key intracellular sensors for pathogen-derived molecules and endogenous danger signals to activate innate immune responses and inflammation. However, the function of most of these receptors still remains unclear.1 Beside the NACHT and LRR domains present in most NLRs, NLRX1/NOD5 possesses a _N_-terminal mitochondrial targeting sequence.2, 3 The function of NLRX1/NOD5 is still controversial; one study proposed that NLRX1/NOD5 inhibits the RIG-like receptor (RLR) antiviral pathways by binding the adaptor protein MAVS/IPS-1/Cardif/VISA,2 whereas another report implicated NLRX1/NOD5 in the generation of reactive oxygen species (ROS) and the amplification of NF-_κ_B and JNK activation triggered by different stimuli such TNF-α, poly (I:C) and Shigella infection.3 Interestingly, a recent study proposed that NLRX1/NOD5 is imported to the mitochondrial matrix, making NLRX1/NOD5 interaction with the outer mitochondrial membrane protein MAVS difficult to explain.4
References
- Schroder K, Tschopp J . Cell 2010; 140: 821–832.
Article CAS Google Scholar - Moore CB et al. Nature 2008; 451: 573–577.
- Tattoli I et al. EMBO Rep 2008; 9: 293–300.
- Arnoult D et al. J Cell Sci 2009; 122 (Part 17): 3161–3168.
- Sun Q et al. Immunity 2006; 24: 633–642.
- Kumar H et al. J Immunol 2010; 186: 994–1000.
- Cui J et al. Cell 2010; 141: 483–496.
- Abdul-Sater AA et al. J Biol Chem 2010; 285: 41637–41645.
Acknowledgements
We thank Professor Jürg Tschopp for the inspiring mentorship and great support over the years. This work was supported by grants from the Swiss National Science Foundation (FNRS 3100A0-128658/1), the Association ‘Institute for Arthritis Research’, the Foundation Louis-Jeantet, and the University of Lausanne.
Author information
Author notes
- J Tschopp: Deceased.
Authors and Affiliations
- Department of Biochemistry, University of Lausanne, Epalinges, CH-1066, Switzerland
M Rebsamen, J Vazquez, A Tardivel, G Guarda & J Tschopp - Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva 4 CH-1211, Switzerland,
J Curran
Authors
- M Rebsamen
- J Vazquez
- A Tardivel
- G Guarda
- J Curran
- J Tschopp
Corresponding author
Correspondence toM Rebsamen.
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on Cell Death and Differentiation website
Supplementary information
Rights and permissions
About this article
Cite this article
Rebsamen, M., Vazquez, J., Tardivel, A. et al. NLRX1/NOD5 deficiency does not affect MAVS signalling.Cell Death Differ 18, 1387 (2011). https://doi.org/10.1038/cdd.2011.64
- Published: 27 May 2011
- Issue date: August 2011
- DOI: https://doi.org/10.1038/cdd.2011.64
This article is cited by
The mitochondrial Nod-like receptor NLRX1 modifies apoptosis through SARM1
- Samuel A. Killackey
- Muhammed A. Rahman
- Stephen E. Girardin
Molecular and Cellular Biochemistry (2019)
NLRX1 promotes immediate IRF1-directed antiviral responses by limiting dsRNA-activated translational inhibition mediated by PKR
- Hui Feng
- Erik M Lenarcic
- Stanley M Lemon
Nature Immunology (2017)
Ubiquitin signaling in immune responses
- Hongbo Hu
- Shao-Cong Sun
Cell Research (2016)
Nlrx1 regulates neuronal cell death
- Emilie Imbeault
- Tara M Mahvelati
- Denis Gris
Molecular Brain (2014)
The inflammasome: in memory of Dr. Jurg Tschopp
- M Dagenais
- A Skeldon
- M Saleh
Cell Death & Differentiation (2012)